c-Met comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-12. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | Derived from angiotensin IV and modified for stability. |
| Proposed mechanism | c-Met/HGF pathway activation | Described as an HGF mimetic in experimental systems. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Name usage varies by supplier and publication. |
| Regulatory status | Not approved as a drug | Sold as a research chemical in some markets. |
| Human trial data | Limited or absent | Most evidence comes from preclinical studies. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Medical acupuncture attempts to integrate reflexological concepts, the trigger point model, and anatomical insights (such as dermatome distribution) into acupuncture practice, and emphasizes a more formulaic approach to acupuncture point location. Cosmetic acupuncture is the use of acupuncture in an attempt to reduce wrinkles on the face. Bee venom acupuncture is a treatment approach of injecting purified, diluted bee venom into acupoints. Veterinary acupuncture is the use of acupuncture on domesticated animals.
== Abbreviations and nomenclature == Abbreviations for "arbitrary unit" include: arb. unit, arb. u., AU, and a.u. Among these, "AU" and "a.u." are common abbreviations for astronomical units and atomic units. For this reason, Physical Review journals, the Japanese Journal of Applied Physics, and an increasing number of other academic journals, recommend against using "a.u." (Jpn. J. Appl. Phys recommends "arb. unit" instead). In UCUM, arbitrary unit is represented as "[arb'U]". While arbitrary unit is not a formally recognized unit, IUPAC and IFCC recognize the need to deal with "unknown units", and decided in 2008 to use the term "procedure defined unit" in their database. The decision forbids using factors or denominators in conjunction with p.d.u. (such as "p.d.u./L").
Zinc makes up about 70 ppm (0.007%) of Earth's crust in mass, making it the 24th-most abundant crustal element. It also makes up 312 ppm of the Solar System, where it is the 22nd most abundant element. Typical background concentrations of zinc do not exceed: 1 μg/m3 in atmosphere, 300 mg/kg in soil, 100 mg/kg in vegetation, 20 μg/L in freshwater, and 5 μg/L in seawater. The element is normally found in association with other base metals such as copper and lead in the form of ores. Zinc is a chalcophile, meaning the element is more likely to be found associated with sulfur and other heavy chalcogens, rather than with the light chalcogen oxygen or with non-chalcogen electronegative elements such as the halogens. Sulfides formed as the crust solidified under the highly reducing conditions of the young Earth's atmosphere. Sphalerite, a crystalline form of zinc sulfide, is the most heavily mined zinc-containing ore as it contains 60–62% zinc by mass. Other source minerals for zinc include smithsonite (zinc carbonate), hemimorphite (zinc silicate), wurtzite (another zinc sulfide), and sometimes hydrozincite (basic zinc carbonate). With the exception of wurtzite, all the other minerals were formed by weathering of the primordial zinc sulfides. Currently identified zinc resources across the globe total 1.9–2.8 billion tonnes. Large deposits are in Australia, China, Canada, and the United States, with the largest potential reserves in Iran.
In the 1950s, the de-Stalinisation of the Soviet Union was ideological bad news for the People's Republic of China because Soviet and Russian interpretations and applications of Leninism and orthodox Marxism contradicted the Sinified Marxism–Leninism of Mao Zedong—his Chinese adaptations of Stalinist interpretation and praxis for establishing socialism in China. To realise that leap of Marxist faith in the development of Chinese socialism, the Chinese Communist Party developed Maoism as the official state ideology. As the specifically Chinese development of Marxism–Leninism, Maoism illuminated the cultural differences between the European-Russian and the Asian-Chinese interpretations and practical applications of Marxism–Leninism in each country. The political differences then provoked geopolitical, ideological and nationalist tensions, which derived from the different stages of development, between the urban society of the industrialised Soviet Union and the agricultural society of the pre-industrial China. The theory versus praxis arguments escalated to theoretic disputes about Marxist–Leninist revisionism and provoked the Sino-Soviet split (1956–1966) and the two countries broke their international relations (diplomatic, political, cultural and economic). China's Great Leap Forward, an idealistic massive reform project, resulted in an estimated 15 to 55 million deaths between 1959 and 1961, mostly from starvation.
Sources: en.wikipedia.org
==== Hadi makes inroads ==== National reconciliation talks were held with the participation of many separatist elements, as well as the Houthis. Nine years after the death of Hussein Badreddin al-Houthi, the Yemeni government turned over the remains of the Houthi patriarch to his family and he was buried in northern Yemen in June 2013, with a representative of the Hadi administration in attendance. Hadi visited the United States, a key overseas ally, in July 2013. The U.S. also lifted a ban on transferring detainees from its Guantanamo Bay detention camp in Cuba to Yemen. Meanwhile, Saudi Arabia deported as many as 300,000 to 400,000 Yemeni migrant workers to their home country during 2013, causing an influx of poor, landless Yemenis into northern Yemen.
== External links == Media related to Parathyroid hormone at Wikimedia Commons Parathyroid hormone: analyte monograph - the Association for Clinical Biochemistry and Laboratory Medicine Overview of all the structural information available in the PDB for UniProt: P01270 (Parathyroid hormone) at the PDBe-KB.
=== Coloration in mammals === The MC1R protein lies within the cell membrane, and is signalled by melanocyte-stimulating hormone (MSH) released by the pituitary gland. When activated by one of the variants of MSH, typically α-MSH, MC1R initiates a complex signaling cascade that leads to the production of eumelanin. In contrast, the receptor can also be antagonized by agouti signalling peptide (ASIP), which reverts the cell back to producing the yellow or red phaeomelanin. The yellow and black agouti banding pattern observed on most mammalian hair is caused by the pulsative nature of ASIP signalling through MC1R. Exceptions include particoloured bay horses, which have reddish bodies, and black legs, mane, and tail, where ASIP signaling is limited to regions instead of pulsating. Human hair, which is neither banded nor particoloured, is thought to be regulated by α-MSH signaling through MC1R exclusively. The prevalence of red hair in humans varies considerably worldwide. In the United States, about 25% of the human population carries the mutated melanocortin 1 receptor that causes red hair. With one in four people as carriers, the chance of two people having a child with red hair is about 2% (one in 64). People with freckles and no red hair have an 85% chance of carrying the MC1R gene that is connected to red hair. People with no freckles and no red hair have an 18% chance of carrying the MC1R gene linked to red hair. Eight genes have been identified in humans that control whether the MC1R gene is turned on and the person has red hair.
Sources: en.wikipedia.org
=== Solution === Unmodified chitosan is generally insoluble in pure water, but dissolves in dilute acidic solutions (pH < 6). It is insoluble in most organic solvents. This is because chitosan behaves like a strong base, with its primary amine groups having a pKa of about 6.3 for the reaction R-NH+3 ⇌ R−NH2 + H+. When enough hydrogen ions are present, the amine group becomes protonated, giving it a positive charge. This allows water molecules to better "pick up" chitosan in the form of a water-soluble cationic polyelectrolyte. Chitosan readily forms soluble salts with many organic acid anions, including formate, acetate, lactate, malate, citrate, glyoxylate, pyruvate, glycolate, and ascorbate. Chitosan can also be dissolved in aqueous CO2, which is useful for minimizing excess acidity. The solubility and pKa of chitosan is affected by DD%. How the acetyl groups are distributed on the chain also matters. As a polyelectrolyte, the protonation behavior of chitosan is best described by Kachalsky's equation.
=== Class I Amidotransferase Domain === The amidotransferase domain is responsible for removal of the amide nitrogen from the glutamine substrate. The class I amidotransferase domain is made of the N terminal 206 residues of the enzyme, and consists of 12 beta strands and 5 alpha helices; the core of this domain is an open 7-stranded mixed beta sheet. Its catalytic triad includes Cys86, His181 and Glu183. His181 is a base and Glu183 is a Hydrogen bond acceptor from the Histidine imidazole ring. Cys86 is the catalytic residue and is conserved. It falls into a nucleophile elbow, where it is at the end of a beta strand and the beginning of an alpha helix, and has little flexibility in its phi and psi angles; thus, Gly84 and Gly88 are conserved and allow for the tight packing of amino acids surrounding the catalytic residue.
During 1973–2013, Khavinson et al., extracted from various organs over 20 complexes of physiologically active peptides, as well as 15 others synthesized from amino acids, (di-, tri-, tetrapeptides), all being covered by patents in many countries including the US, Canada, Australia, Europe, Japan, Korea, Israel, etc. After many years of experimental and clinical studies, six medicinal peptide preparations were permitted for medical use in the USSR, Russia, and afterward in the CIS countries. They were primarily to be used by the military medical service. These are ‘Thymalin’- a preparation of the thymus, being a cellular immunity regulator; ‘Epithalamin’ — a preparation from the pineal gland — regulator of the endocrine system, which restores melatonin, (with no analogues worldwide) ‘Cortexin’ — a preparation from the cerebral cortex, brain function regulator; ‘Prostatilen’ or ‘Samprost’ or ‘Vitaprost’ — a preparation from the prostate gland, regulator of prostate function; ‘Retinalamin’ — a preparation from the retina, partially restores functions of the retina in case of laser lesions and degenerative diseases, has no analogues worldwide; ‘Thymogen’ — a dipeptide EW, being first extracted from ‘Thymalin’, then synthesized from amino acids, regulates immunity. These medicinal peptide preparations were first used to restore immune functions of the brain, endocrine system, retina, etc.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide derived from angiotensin IV and studied for effects on synaptic plasticity. It is often described as a hepatocyte growth factor mimetic. It is not an approved medication.
It is based on angiotensin IV, a naturally occurring peptide fragment, but dihexa itself is chemically modified and synthetic. The modifications aim to improve stability and activity compared with the parent fragment.
Laboratory studies have used cell-based assays and rodent models. These examine receptor signaling, dendritic spine changes, and behavioral tasks. Published human clinical trial data are lacking.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.